OBJECTIVE: Worldwide, genital warts, caused by human papillomavirus (HPV) is a
common, sexually transmitted disease. The overall disease management strategy for genital …

Objective: This study examined the incidence of and healthcare costs attributable to genital
warts within a large US commercially insured, geographically dispersed population …

Background This study estimated genital warts prevalence, genital-warts-related healthcare
resource use and costs, and self-reported human-papillomavirus-related psychosocial …

Objective: Genital warts are caused by human papillomavirus (HPV), principally types 6 and
11, and are highly contagious. This study assessed treatment patterns and costs of …

Objectives To estimate the loss of quality of life and cost of treatment associated with genital
warts seen in sexual health clinics. Methods A cross-sectional questionnaire study and case …

Background: Data on the burden of genital warts in terms of treatment costs and detriment to
quality of life (QoL) are required to assess cost-effectiveness of quadrivalent human …

Background Human papillomavirus (HPV) is a necessary cause of cervical cancer. HPV is
also responsible for benign condylomata acuminata, also known as genital warts. We …

Objective The quadrivalent human papillomavirus (HPV) vaccine is effective against HPV
types responsible for 90% of anogenital warts. This study estimated the quality of life lost to …

Objectives To estimate for the first time the incidence and healthcare resource utilisation
associated with genital warts (GW) in Australia prior to the human papillomavirus …

Background: Genital warts (GW) are common and increasing in young people. Ninety
percent of GW are due to Human Papillomavirus (HPV) types 6 and 11. The objective of this …